Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 16 January 2009:
Vol. 323. no. 5912, pp. 393 - 396
DOI: 10.1126/science.1167375

Reports

Recombination of Retrotransposon and Exogenous RNA Virus Results in Nonretroviral cDNA Integration

Markus B. Geuking,1*{dagger} Jacqueline Weber,1{ddagger} Marie Dewannieux,2 Elieser Gorelik,3 Thierry Heidmann,2 Hans Hengartner,1 Rolf M. Zinkernagel,1{dagger}§ Lars Hangartner1{dagger}§||

Retroviruses have the potential to acquire host cell–derived genetic material during reverse transcription and can integrate into the genomes of larger, more complex DNA viruses. In contrast, RNA viruses were believed not to integrate into the host's genome under any circumstances. We found that illegitimate recombination between an exogenous nonretroviral RNA virus, lymphocytic choriomeningitis virus, and the endogenous intracisternal A-type particle (IAP) retrotransposon occurred and led to reverse transcription of exogenous viral RNA. The resulting complementary DNA was integrated into the host's genome with an IAP element. Thus, RNA viruses should be closely scrutinized for any capacity to interact with endogenous retroviral elements before their approval for therapeutic use in humans.

1 Institute of Experimental Immunology, University Hospital Zürich, Schmelzbergstrasse 12, 8091 Zürich, Switzerland.
2 CNRS Unité Mixte de Recherche 8122, Unité des Rétrovirus Endogènes et Eléments Rétroïdes des Eucaryotes Supérieurs, Institut Gustave Roussy, 94805 Villejuif Cedex and Université Paris-Sud 91405 Orsay, France.
3 University of Pittsburgh Cancer Institute, Hillman Cancer Center, Room 1.46, Pittsburgh, PA 15232, USA.

* Present address: Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, ON L8N 3Z5, Canada.

{ddagger} Present address: Institut für Molekulare Biomedizin, ETH Zürich, Wagistrasse 27, 8952 Schlieren, Switzerland.

§ These authors contributed equally to this work.

|| Present address: Institute of Medical Virology, University of Zurich, Gloriastrasse 30, 8006 Zurich, Switzerland.

{dagger} To whom correspondence should be addressed. E-mail: hangartner.lars{at}virology.uzh.ch (L.H.); geuking{at}mcmaster.ca (M.B.G.); rolf.zinkernagel{at}usz.ch (R.M.Z.)

Read the Full Text





To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)